マーケットレポート詳細
医薬品原薬(API)の世界市場：タイプ別、治療領域別2027年予測
Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormones, Cytokines), Drug (OTC,Rx) Application (Diabetes, Oncology, CVD) - Global Forecast to 2027
- 出版元：MarketsandMarkets
出版元について - 発行年：2022年12月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文361ページになります。
- 商品コード：MAM3141
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
医薬品原薬(API)の世界市場規模は2022年で1459億ドル、2027年に2164億ドル、市場の平均年成長率は8.2%になると当レポートは予測しています。
同市場の成長要因として、バイオ医薬品の普及、ジェネリック医薬品の重要性の高まり、精密医療への注目の高まりなどが挙げられます。
レポートは医薬品原薬(API)の世界市場について2027年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（タイプ別市場、効能別市場、等）を中心に構成されています。また競合状況、主要企業情報（19社）、エコシステム分析、ファイブフォース分析などの分析も加味し、医薬品原薬(API)市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆医薬品原薬(API)の世界市場予測2020-2027年
・市場規模(US$)
◆タイプ別、市場-2027年
・新薬
・ジェネリック医薬品
※(市場規模US$)
◆効能別、市場-2027年
・従来型API
・高薬理API
※(市場規模US$)
◆合成タイプ別、市場-2027年
＜合成API＞
合成API市場、タイプ別
・新薬
・ジェネリック医薬品
＜バイオAPI＞
バイオAPI市場、タイプ別
・新薬
・ジェネリック医薬品
バイオAPI市場、製品別
・モノクローナル抗体
・ホルモン/成長因子
・サイトカイン
・融合タンパク質
・組み換えワクチン
・治療用酵素
・血液因子
バイオAPI市場、発現系別
・哺乳動物発現系
・微生物発現系
・酵母発現系
・昆虫発現系
・その他発現系
※(市場規模US$)
◆医薬品タイプ別、市場-2027年
・処方薬
・一般用医薬品（OTC）
※(市場規模US$)
◆治療領域別、市場-2027年
・伝染病
・腫瘍
・糖尿病
・心血管疾患
・疼痛管理
・呼吸器疾患
・その他治療領域
※(市場規模US$)
◆主要国地域別市場-2027年
北米
・米国、カナダ
欧州
・ドイツ、フランス、英国
・イタリア、スペイン、ハンガリー
・その他欧州
アジア太平洋
・日本、中国、インド、韓国
・その他アジア太平洋
その他地域
・イスラエル
・その他国
※国地域別に全セグメント別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス(ドライバー、障壁、機会、課題)
・バリューチェーン分析
・エコシステム分析
・特許分析
・ファイブフォース分析
・価格分析
・市場シェア分析
・競合状況
◆医薬品原薬(API)の主要企業プロフィール動向
・PFIZER INC.
・TEVA PHARMACEUTICAL INDUSTRIES LTD.
・DIVI’S LABORATORIES LIMITED
・VIATRIS INC.
・NOVARTIS AG
・SANOFI
・BOEHRINGER INGELHEIM
・BRISTOL-MYERS SQUIBB
・ELI LILLY AND COMPANY
・GLAXOSMITHKLINE PLC
・MERCK & CO., INC.
・ABBVIE INC.
・F. HOFFMANN-LA ROCHE LTD.
・ASTRAZENECA
・DR. REDDY’S LABORATORIES LTD.
・SUN PHARMACEUTICAL INDUSTRIES LTD.
・CIPLA INC.
・AUROBINDO PHARMA
・EVONIK INDUSTRIES AG
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1.... INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED.. 49
・ FIGURE 1............................................... MARKET SEGMENTATION
1.3.2 GEOGRAPHIC SCOPE. 49
1.3.3 YEARS CONSIDERED.. 50
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2.... RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 2...................................................... RESEARCH DESIGN.. 52
2.1.1 SECONDARY DATA
2.1.1.1 KEY DATA FROM SECONDARY SOURCES
2.1.2 PRIMARY DATA
2.1.2.1 PRIMARY SOURCES
2.1.2.2 KEY DATA FROM PRIMARY SOURCES
・ FIGURE 3............................ BREAKDOWN OF PRIMARY INTERVIEWS
2.2 MARKET SIZE ESTIMATION
・ FIGURE 4......... MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
・ FIGURE 5............ MARKET SIZE ESTIMATION: DEMAND-SIDE ANALYSIS
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
・ FIGURE 6.............................. DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS
3.... EXECUTIVE SUMMARY
・ FIGURE 7... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022 VS. 2027 (USD BILLION)
・ FIGURE 8. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY TYPE OF SYNTHESIS, 2021
・ FIGURE 9........... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2022 VS. 2027 (USD BILLION)
・ FIGURE 10.. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2022 VS. 2027 (USD BILLION)
・ FIGURE 11 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY THERAPEUTIC APPLICATION, 2021
・ FIGURE 12... GEOGRAPHICAL SNAPSHOT OF ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
4.... PREMIUM INSIGHTS
4.1 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET OVERVIEW
・ FIGURE 13... INCREASING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
4.2 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE AND COUNTRY (2021)
・ FIGURE 14...... INNOVATIVE APIS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
4.3 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 15.. ASIA PACIFIC TO WITNESS HIGHEST GROWTH IN FORECAST PERIOD
5.... MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 16 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 PHARMACEUTICAL AND BIOPHARMACEUTICAL CAPACITY EXPANSION
5.2.1.2 GROWING IMPORTANCE OF GENERICS
・ TABLE 1............. INDICATIVE LIST OF DRUGS GOING GENERIC IN 2021
5.2.1.3 INCREASING UPTAKE OF BIOPHARMACEUTICALS
・ TABLE 2 US: INDICATIVE LIST OF BIOLOGICS THAT GAINED REGULATORY APPROVAL IN 2021
5.2.1.4 TECHNOLOGICAL ADVANCEMENTS IN API MANUFACTURING
5.2.1.5 FOCUS ON PRECISION MEDICINE
5.2.1.6 INCREASING INCIDENCE OF CHRONIC DISEASES
5.2.2 RESTRAINTS
5.2.2.1 COMPLICATIONS DURING API MANUFACTURING
5.2.2.2 LOW PROFIT MARGINS AND HIGH MANUFACTURING COSTS
5.2.3 OPPORTUNITIES
5.2.3.1 EMERGING BIOSIMILARS MARKET
・ TABLE 3............... US: INDICATIVE LIST OF BIOSIMILARS THAT GAINED REGULATORY APPROVAL (2021–2022)
5.2.3.2 HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS
5.2.3.3 EMERGING MARKETS
5.2.3.4 EMERGING TECHNOLOGIES/PROCESSES
5.2.4 CHALLENGES
5.2.4.1 INCREASING PENETRATION OF COUNTERFEIT DRUGS
5.3 VALUE CHAIN ANALYSIS.. 77
・ FIGURE 17.............. MAJOR VALUE ADDED DURING MANUFACTURING
5.4 SUPPLY CHAIN ANALYSIS
・ FIGURE 18............. DIRECT DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES
5.5 ECOSYSTEM ANALYSIS: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
・ FIGURE 19......... ECOSYSTEM ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
5.6 PATENT ANALYSIS
・ FIGURE 20........ PATENT APPLICATIONS FOR ACTIVE PHARMACEUTICAL INGREDIENTS, JANUARY 2010–DECEMBER 2021.. 80
5.7 KEY CONFERENCES AND EVENTS
・ TABLE 4... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2022–2023
5.8 TARIFF AND REGULATORY LANDSCAPE
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 5.......... NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 8... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF SUPPLIERS
5.9.4 BARGAINING POWER OF BUYERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
・ FIGURE 21..... INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ACTIVE PHARMACEUTICAL INGREDIENTS
5.10.2 BUYING CRITERIA FOR ACTIVE PHARMACEUTICAL INGREDIENTS
・ FIGURE 22........................... KEY BUYING CRITERIA FOR END USERS
5.11 PRICING ANALYSIS
・ TABLE 9.................. IMPORTERS FOR ANTIBIOTICS (HS CODE – 2941)
・ TABLE 10................. EXPORTERS FOR ANTIBIOTICS (HS CODE – 2941)
・ TABLE 11 IMPORTERS FOR NUCLEIC ACIDS AND THEIR SALTS, WHETHER OR NOT CHEMICALLY DEFINED; HETEROCYCLIC COMPOUNDS (EXCLUDING WITH OXYGEN ONLY OR WITH NITROGEN HETERO-ATOM[S] ONLY (HS CODE – 2934)
・ TABLE 12 EXPORTERS FOR NUCLEIC ACIDS AND THEIR SALTS, WHETHER OR NOT CHEMICALLY DEFINED; HETEROCYCLIC COMPOUNDS (EXCLUDING WITH OXYGEN ONLY OR WITH NITROGEN HETERO-ATOM[S] ONLY (HS CODE – 2934)
・ TABLE 13............... IMPORTERS FOR HORMONES, PROSTAGLANDINS, THROMBOXANES, AND LEUKOTRIENES, NATURAL OR REPRODUCED BY SYNTHESIS; DERIVATIVES AND STRUCTURAL ANALOGUES THEREOF INCLUDE CHAIN-MODIFIED POLYPEPTIDES, USED PRIMARILY AS HORMONES (HS CODE – 2937)
・ TABLE 14............... EXPORTERS FOR HORMONES, PROSTAGLANDINS, THROMBOXANES AND LEUKOTRIENES, NATURAL OR REPRODUCED BY SYNTHESIS; DERIVATIVES AND STRUCTURAL ANALOGUES THEREOF INCLUDE CHAIN-MODIFIED POLYPEPTIDES, USED PRIMARILY AS HORMONES (HS CODE – 2937)
5.12 TRADE ANALYSIS
・ TABLE 15....... TOP 10 IMPORTERS FOR ANTIBIOTICS (HS CODE – 2941)
・ TABLE 16......... TOP 10 EXPORTERS OF ANTIBIOTICS (HS CODE – 2941)
・ TABLE 17..... TOP 10 IMPORTERS OF NUCLEIC ACIDS AND THEIR SALTS, WHETHER OR NOT CHEMICALLY DEFINED; HETEROCYCLIC COMPOUNDS (EXCLUDING WITH OXYGEN ONLY OR WITH NITROGEN HETERO-ATOM[S] ONLY (HS CODE – 2934)
・ TABLE 18..... TOP 10 EXPORTERS OF NUCLEIC ACIDS AND THEIR SALTS, WHETHER OR NOT CHEMICALLY DEFINED; HETEROCYCLIC COMPOUNDS (EXCLUDING WITH OXYGEN ONLY OR WITH NITROGEN HETERO-ATOM[S] ONLY (HS CODE – 2934)
・ TABLE 19....... TOP 10 IMPORTERS OF HORMONES, PROSTAGLANDINS, THROMBOXANES AND LEUKOTRIENES, NATURAL OR REPRODUCED BY SYNTHESIS; DERIVATIVES AND STRUCTURAL ANALOGUES THEREOF INCLUDE CHAIN-MODIFIED POLYPEPTIDES, USED PRIMARILY AS HORMONES (HS CODE – 2937)
・ TABLE 20....... TOP 10 EXPORTERS OF HORMONES, PROSTAGLANDINS, THROMBOXANES AND LEUKOTRIENES, NATURAL OR REPRODUCED BY SYNTHESIS; DERIVATIVES AND STRUCTURAL ANALOGUES THEREOF INCLUDE CHAIN-MODIFIED POLYPEPTIDES, USED PRIMARILY AS HORMONES (HS CODE – 2937)
6.... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
6.1 INTRODUCTION
・ TABLE 21... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
6.2 ACTIVE PHARMACEUTICAL INGREDIENTS, BY TYPE (CAPTIVE AND MERCHANT)
・ TABLE 22.... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE (CAPTIVE AND MERCHANT), 2020–2027 (USD BILLION)
・ TABLE 23 CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
6.3 INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS
6.3.1 GROWING NUMBER OF NEW MOLECULAR ENTITIES GAINING REGULATORY APPROVALS TO DRIVE MARKET
・ TABLE 24........... INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION). 97
・ TABLE 25...... NORTH AMERICA: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 26 EUROPE: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 27........... ASIA PACIFIC: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 28. REST OF THE WORLD: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION). 99
6.4 GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS
6.4.1 GOVERNMENT INITIATIVES SUPPORTING ADOPTION OF GENERIC DRUGS TO BOOST MARKET GROWTH
・ TABLE 29.. GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 30.......... NORTH AMERICA: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 31.. EUROPE: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 32.............. ASIA PACIFIC: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 33..... REST OF THE WORLD: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
7.... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY
7.1 INTRODUCTION
・ TABLE 34........... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION)
7.2 TRADITIONAL ACTIVE PHARMACEUTICAL INGREDIENTS
7.2.1 APPLICATION IN VARIOUS THERAPEUTIC AREAS TO SUPPORT MARKET GROWTH
・ TABLE 35......... TRADITIONAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION). 104
・ TABLE 36.... NORTH AMERICA: TRADITIONAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 37............... EUROPE: TRADITIONAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 38......... ASIA PACIFIC: TRADITIONAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 39 REST OF THE WORLD: TRADITIONAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
7.3 HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS
7.3.1 INCREASING APPLICATION ACROSS RANGE OF THERAPEUTIC AREAS TO DRIVE MARKET
・ TABLE 40...... HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION). 106
・ TABLE 41. NORTH AMERICA: HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION). 106
・ TABLE 42............ EUROPE: HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 43...... ASIA PACIFIC: HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 44...................... REST OF THE WORLD: HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
8.... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS
8.1 INTRODUCTION
・ TABLE 45 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
8.2 ACTIVE PHARMACEUTICAL INGREDIENTS, BY TYPE OF SYNTHESIS
(CAPTIVE AND MERCHANT)
・ TABLE 46 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS (CAPTIVE AND MERCHANT), 2020–2027 (USD BILLION)
・ TABLE 47 CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
8.3 SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS
・ TABLE 48 SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 49....... NORTH AMERICA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 50 EUROPE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 51............ ASIA PACIFIC: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION). 113
・ TABLE 52... REST OF THE WORLD: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION). 114
8.3.1 SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
・ TABLE 53 SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
8.3.1.1 INNOVATIVE SYNTHETIC APIS
8.3.1.1.1 HIGH VALUE OF INNOVATIVE APIS TO DRIVE MARKET
・ TABLE 54.............. INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 55................ NORTH AMERICA: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 56.. EUROPE: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION). 116
・ TABLE 57..................... ASIA PACIFIC: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 58........... REST OF THE WORLD: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
8.3.1.2 GENERIC SYNTHETIC APIS
8.3.1.2.1 INITIATIVES TO PROMOTE PENETRATION OF GENERICS TO SUPPORT MARKET GROWTH
・ TABLE 59 GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 60.................... NORTH AMERICA: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 61...... EUROPE: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 62 ASIA PACIFIC: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 63............... REST OF THE WORLD: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
8.4 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS
・ TABLE 64 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 65.......... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 66... EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 67............... ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 68..... REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION). 123
8.4.1 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
・ TABLE 69 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
8.4.1.1 INNOVATIVE BIOTECH APIS
8.4.1.1.1 GROWING DEMAND FOR INNOVATIVE BIOPHARMACEUTICALS TO DRIVE MARKET. 123
・ TABLE 70 INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION). 124
・ TABLE 71.................. NORTH AMERICA: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 72..... EUROPE: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 73....................... ASIA PACIFIC: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 74.............. REST OF THE WORLD: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
8.4.1.2 GENERIC BIOTECH APIS
8.4.1.2.1 INCREASING DEMAND FOR BIOSIMILAR DRUGS DUE TO COST-EFFECTIVENESS TO DRIVE MARKET
・ TABLE 75.. GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 76...................... NORTH AMERICA: GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 77......... EUROPE: GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 78.. ASIA PACIFIC: GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION). 128
・ TABLE 79.................. REST OF THE WORLD: GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
8.4.2 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT
・ TABLE 80 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION)
8.4.2.1 MONOCLONAL ANTIBODIES
8.4.2.1.1 GROWING APPLICATIONS OF ANTIBODY-DRUG CONJUGATES IN TREATMENT OF CANCER TO DRIVE GROWTH
・ TABLE 81... BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 82.......... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 83... EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 84............... ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 85..... REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2020–2027 (USD BILLION)
8.4.2.2 HORMONES AND GROWTH FACTORS
8.4.2.2.1 GROWING INCIDENCE OF HORMONAL DISORDERS TO DRIVE MARKET
・ TABLE 86... BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES AND GROWTH FACTORS, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 87.......... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES & GROWTH FACTORS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 88... EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES & GROWTH FACTORS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 89............... ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES & GROWTH FACTORS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 90..... REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES & GROWTH FACTORS, BY COUNTRY, 2020–2027 (USD BILLION)
8.4.2.3 CYTOKINES
8.4.2.3.1 INTERFERONS AND INTERLEUKINS BOOST IMMUNE SYSTEM
・ TABLE 91... BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 92.......... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 93... EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 94............... ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 95..... REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 2020–2027 (USD BILLION)
8.4.2.4 FUSION PROTEINS
8.4.2.4.1 GROWING APPLICATIONS OF FUSION PROTEINS IN BIOPHARMACEUTICALS TO DRIVE MARKET. 137
・ TABLE 96... BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY REGION, 2020–2027 (USD BILLION). 138
・ TABLE 97.......... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 98... EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 99............... ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 100... REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 2020–2027 (USD BILLION)
8.4.2.5 RECOMBINANT VACCINES
8.4.2.5.1 GROWING PREVALENCE OF INFECTIOUS DISEASES TO BOOST VACCINE DEVELOPMENT
・ TABLE 101.. BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 102........ NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 103. EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 104............. ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 105... REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 2020–2027 (USD BILLION)
8.4.2.6 THERAPEUTIC ENZYMES
8.4.2.6.1 GROWING SIGNIFICANCE OF ENZYMES IN THERAPIES FOR CANCER AND PAIN MANAGEMENT TO DRIVE MARKET
・ TABLE 106.. BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 107........ NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 108. EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 109............. ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 110... REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, 2020–2027 (USD BILLION)
8.4.2.7 BLOOD FACTORS
8.4.2.7.1 GROWING INCIDENCE OF HEMOPHILIA TO DRIVE MARKET
・ TABLE 111.. BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 112........ NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 113. EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 114............. ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 115... REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, 2020–2027 (USD BILLION)
8.4.3 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM
・ TABLE 116. BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
8.4.3.1 MAMMALIAN EXPRESSION SYSTEMS
8.4.3.1.1 ABILITY TO CARRY POST-TRANSLATIONAL MODIFICATIONS TO DRIVE ADOPTION.. 148
・ TABLE 117.. BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 118........ NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 119. EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 120............. ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 121... REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
8.4.3.2 MICROBIAL EXPRESSION SYSTEMS
8.4.3.2.1 HIGH EXPRESSION LEVELS OF PROTEINS AT LOW COSTS TO DRIVE MARKET
・ TABLE 122.. BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 123........ NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 124. EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 125............. ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 126... REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
8.4.3.3 YEAST EXPRESSION SYSTEMS
8.4.3.3.1 EFFICIENT PROTEIN SECRETION, SIMPLE PURIFICATION, AND ENDOTOXIN-FREE PRODUCTS TO BOOST DEMAND
・ TABLE 127.. BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 128........ NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 129. EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 130............. ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 131... REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
8.4.3.4 INSECT EXPRESSION SYSTEMS
8.4.3.4.1 EFFICIENT POST-TRANSLATIONAL MODIFICATIONS TO BOOST ADOPTION
・ TABLE 132.. BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 133........ NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 134. EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 135............. ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 136... REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
8.4.3.5 OTHER EXPRESSION SYSTEMS
・ TABLE 137.. BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 138........ NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 139. EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 140............. ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 141... REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION)
9.... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG
9.1 INTRODUCTION
・ TABLE 142.. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
9.2 PRESCRIPTION DRUGS
9.2.1 GROWING DISEASE PREVALENCE TO SUPPORT MARKET GROWTH
・ TABLE 143... PRESCRIPTION DRUGS MARKET, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 144........ NORTH AMERICA: PRESCRIPTION DRUGS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 145..... EUROPE: PRESCRIPTION DRUGS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 146 ASIA PACIFIC: PRESCRIPTION DRUGS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 147 REST OF THE WORLD: PRESCRIPTION DRUGS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
9.3 OVER-THE-COUNTER DRUGS
9.3.1 INCREASED SALES OF OTC DRUGS DUE TO INNOVATIONS, PROMOTION OF SELF-MEDICATION, AND INCREASED ACCESS
・ TABLE 148... OVER-THE-COUNTER DRUGS MARKET, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 149. NORTH AMERICA: OVER-THE-COUNTER DRUGS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 150............ EUROPE: OVER-THE-COUNTER DRUGS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 151...... ASIA PACIFIC: OVER-THE-COUNTER DRUGS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 152 REST OF THE WORLD: OVER-THE-COUNTER DRUGS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
10.. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION
10.1 INTRODUCTION
・ TABLE 153......... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
10.2 COMMUNICABLE DISEASES
10.2.1 LARGEST AND FASTEST-GROWING MARKET SEGMENT
・ TABLE 154........ ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 155.. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 156. EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 157...... ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 158............... REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 2020–2027 (USD BILLION)
10.3 ONCOLOGY
10.3.1 INCREASING SPENDING ON CANCER MEDICATION TO SUPPORT MARKET GROWTH
・ TABLE 159........ ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 160.. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD BILLION). 175
・ TABLE 161. EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 162...... ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 163............... REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD BILLION)
10.4 DIABETES
10.4.1 HIGH PREVALENCE OF DIABETES TO DRIVE MARKET
・ TABLE 164........ ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 165.. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 2020–2027 (USD BILLION). 177
・ TABLE 166. EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 167...... ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 168............... REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 2020–2027 (USD BILLION)
10.5 CARDIOVASCULAR DISEASES
10.5.1 GROWING INCIDENCE OF CARDIOVASCULAR DISEASES OWING TO SEDENTARY LIFESTYLES
・ TABLE 169........ ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 170.. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 171. EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 172...... ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 173............... REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2020–2027 (USD BILLION)
10.6 PAIN MANAGEMENT
10.6.1 INCREASING DEMAND FOR INNOVATIVE AND ADVANCED PAIN MEDICATIONS TO PROPEL MARKET
・ TABLE 174. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 175.. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 176. EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2020–2027 (USD BILLION). 183
・ TABLE 177...... ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 178............... REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2020–2027 (USD BILLION)
10.7 RESPIRATORY DISEASES
10.7.1 HIGH PREVALENCE OF RESPIRATORY DISEASES TO SUPPORT MARKET GROWTH
・ TABLE 179........ ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 180.. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 181. EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 182...... ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 183............... REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2020–2027 (USD BILLION)
10.8 OTHER THERAPEUTIC APPLICATIONS
・ TABLE 184........ ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
・ TABLE 185.. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 186. EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 187...... ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 188............... REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD BILLION)
11.. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION
11.1 INTRODUCTION
・ TABLE 189......... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION)
11.2 NORTH AMERICA
・ FIGURE 23.. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SNAPSHOT
・ TABLE 190.. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 191.. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 192.. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 USD BILLION)
・ TABLE 193...... NORTH AMERICA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 194........ NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 195........ NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION)
・ TABLE 196........ NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 197.. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 198.. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION)
・ TABLE 199.. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.2.1 US
11.2.1.1 LARGEST MARKET FOR ACTIVE PHARMACEUTICAL INGREDIENTS
・ TABLE 200.... US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 201.... US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 202..... US: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 203........ US: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 204........ US: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION). 198
・ TABLE 205........ US: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 206.... US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 207.... US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION)
・ TABLE 208.... US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.2.2 CANADA
11.2.2.1 GROWING PHARMACEUTICAL MANUFACTURING TO SUPPORT MARKET GROWTH
・ TABLE 209 CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 210 CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 211................ CANADA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 212. CANADA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 213. CANADA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION)
・ TABLE 214. CANADA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 215 CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 216 CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION)
・ TABLE 217 CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.3 EUROPE
・ TABLE 218. EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
・ TABLE 219. EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 220. EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 221................. EUROPE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 222. EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 223. EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION)
・ TABLE 224. EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 225. EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 226. EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION)
・ TABLE 227. EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.3.1 GERMANY
11.3.1.1 LEADING COUNTRY IN TERMS OF INFRASTRUCTURE AND COMPETENCY FOR R&D
・ TABLE 228.......... GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 229.......... GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 230.............. GERMANY: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 231................. GERMANY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 232................. GERMANY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION). 211
・ TABLE 233................. GERMANY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 234.......... GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 235.......... GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION). 212
・ TABLE 236.......... GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.3.2 FRANCE
11.3.2.1 HEALTHY PHARMACEUTICAL PRODUCTION TO SUPPORT API DEMAND
・ TABLE 237. FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 238. FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 239................. FRANCE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 240. FRANCE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 241. FRANCE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION)
・ TABLE 242. FRANCE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 243. FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 244. FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION)
・ TABLE 245. FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.3.3 UK
11.3.3.1 RISING GOVERNMENT INVESTMENTS TO DRIVE MARKET
・ TABLE 246.... UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 247.... UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 248..... UK: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 249........ UK: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 250........ UK: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION). 219
・ TABLE 251........ UK: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 252.... UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 253.... UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION)
・ TABLE 254.... UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.3.4 ITALY
11.3.4.1 GROWING INVESTMENT IN API PRODUCTION TO SUPPORT MARKET GROWTH
・ TABLE 255. ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 256. ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 257.. ITALY: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 258..... ITALY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 259..... ITALY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION). 223
・ TABLE 260..... ITALY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 261. ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 262. ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION)
・ TABLE 263. ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.3.5 SPAIN
11.3.5.1 INCREASE IN GENERIC DRUG MANUFACTURING CAPACITY TO PROPEL DEMAND FOR APIS
・ TABLE 264 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 265 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 266. SPAIN: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 267... SPAIN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 268... SPAIN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION)
・ TABLE 269... SPAIN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 270 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 271 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION)
・ TABLE 272 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.3.6 HUNGARY
11.3.6.1 RISING INCIDENCE OF CHRONIC DISEASES TO PROPEL MARKET GROWTH
・ TABLE 273 HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 274 HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 275............... HUNGARY: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 276 HUNGARY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 277 HUNGARY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION)
・ TABLE 278 HUNGARY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 279 HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 280 HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION)
・ TABLE 281 HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.3.7 REST OF EUROPE
・ TABLE 282.. REST OF EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 283.. REST OF EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 284..... REST OF EUROPE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 285........ REST OF EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 286........ REST OF EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION)
・ TABLE 287........ REST OF EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 288.. REST OF EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 289.. REST OF EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION)
・ TABLE 290.. REST OF EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.4 ASIA PACIFIC
・ FIGURE 24...... ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SNAPSHOT
・ TABLE 291...... ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION). 239
・ TABLE 292...... ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 293...... ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 294.......... ASIA PACIFIC: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 295............. ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 296............. ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION)
・ TABLE 297............. ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 298...... ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 299...... ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION). 242
・ TABLE 300...... ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.4.1 JAPAN
11.4.1.1 PRESENCE OF LARGE PHARMACEUTICAL COMPANIES TO PROPEL MARKET
・ TABLE 301 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 302 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 303. JAPAN: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 304... JAPAN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 305... JAPAN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION)
・ TABLE 306... JAPAN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 307 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 308 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION)
・ TABLE 309 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.4.2 CHINA
11.4.2.1 GOVERNMENT POLICIES TO INCREASE MEDICINE ACCESS AND AFFORDABILITY TO SUPPORT MARKET GROWTH
・ TABLE 310 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 311 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 312. CHINA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 313... CHINA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 314... CHINA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION)
・ TABLE 315... CHINA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 316 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 317 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION)
・ TABLE 318 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.4.3 INDIA
11.4.3.1 LEADING PRODUCER OF GENERICS
・ TABLE 319 INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 320 INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 321.. INDIA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 322.... INDIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 323.... INDIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION). 253
・ TABLE 324.... INDIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 325 INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 326 INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION)
・ TABLE 327 INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.4.4 SOUTH KOREA
11.4.4.1 RISING ANNUAL DRUG EXPORTS TO DRIVE MARKET
・ TABLE 328..... SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 329..... SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 330......... SOUTH KOREA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 331........... SOUTH KOREA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 332........... SOUTH KOREA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION)
・ TABLE 333........... SOUTH KOREA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 334..... SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 335..... SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION). 258
・ TABLE 336..... SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.4.5 REST OF ASIA PACIFIC
・ TABLE 337.............. REST OF ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 338.............. REST OF ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 339 REST OF ASIA PACIFIC: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 340.. REST OF ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 341.. REST OF ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION). 261
・ TABLE 342.. REST OF ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 343.............. REST OF ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 344.............. REST OF ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION)
・ TABLE 345.............. REST OF ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.5 REST OF THE WORLD
・ TABLE 346............... REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION). 263
・ TABLE 347............... REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 348............... REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 349. REST OF THE WORLD: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 350... REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 351... REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION). 265
・ TABLE 352... REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 353............... REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 354............... REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION). 266
・ TABLE 355............... REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.5.1 ISRAEL
11.5.1.1 FINANCIAL SUPPORT BY GOVERNMENT TO DRIVE MARKET
・ TABLE 356.. ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 357.. ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 358 ISRAEL: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 359.. ISRAEL: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 360.. ISRAEL: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION)
・ TABLE 361.. ISRAEL: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 362.. ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 363.. ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION)
・ TABLE 364.. ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
11.5.2 OTHER COUNTRIES.. 271
・ TABLE 365 OTHER COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 366 OTHER COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION)
・ TABLE 367... OTHER COUNTRIES: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 368...... OTHER COUNTRIES: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION)
・ TABLE 369...... OTHER COUNTRIES: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION)
・ TABLE 370...... OTHER COUNTRIES: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION)
・ TABLE 371 OTHER COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION)
・ TABLE 372 OTHER COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION)
・ TABLE 373 OTHER COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION)
12.. COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 STRATEGIES ADOPTED BY KEY PLAYERS
・ FIGURE 25............. KEY DEVELOPMENTS IN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, 2019–2022
12.3 MARKET SHARE ANALYSIS
・ FIGURE 26.... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
・ TABLE 374.. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: DEGREE OF COMPETITION
12.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
・ FIGURE 27....... REVENUE SHARE ANALYSIS OF TOP PLAYERS IN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, 2019–2021
12.5 COMPANY EVALUATION QUADRANT
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
・ FIGURE 28 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION QUADRANT, 2021
12.6 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES
12.6.1 PROGRESSIVE COMPANIES
12.6.2 STARTING BLOCKS
12.6.3 RESPONSIVE COMPANIES
12.6.4 DYNAMIC COMPANIES
・ FIGURE 29 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES, 2021
12.7 REGIONAL FOOTPRINT OF COMPANIES
・ TABLE 375............... REGIONAL FOOTPRINT OF COMPANIES IN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET (2021)
12.8 COMPETITIVE SCENARIO
・ TABLE 376............................................ KEY PRODUCT LAUNCHES
・ TABLE 377................................................................ KEY DEALS
・ TABLE 378......................................... OTHER KEY DEVELOPMENTS
13.. COMPANY PROFILES
13.1 KEY PLAYERS
(BUSINESS OVERVIEW, PRODUCTS/SERVICES/SOLUTIONS OFFERED, MNM VIEW, KEY STRENGTHS AND RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESSES AND COMPETITIVE THREATS, RECENT DEVELOPMENTS)*
13.1.1 PFIZER INC.
・ TABLE 379................................. PFIZER INC.: COMPANY OVERVIEW
・ FIGURE 30...................... PFIZER, INC.: COMPANY SNAPSHOT (2021)
13.1.2 TEVA PHARMACEUTICAL INDUSTRIES LTD.
・ TABLE 380......... TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY OVERVIEW
・ FIGURE 31......... TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT (2021)
13.1.3 DIVI’S LABORATORIES LIMITED
・ TABLE 381......... DIVI’S LABORATORIES LIMITED: COMPANY OVERVIEW
・ FIGURE 32........ DIVI’S LABORATORIES LIMITED: COMPANY SNAPSHOT (2021)
13.1.4 VIATRIS INC.
・ TABLE 382................................ VIATRIS INC.: COMPANY OVERVIEW
・ FIGURE 33...................... VIATRIS INC.: COMPANY SNAPSHOT (2021)
13.1.5 NOVARTIS AG
・ TABLE 383............................... NOVARTIS AG: COMPANY OVERVIEW
・ FIGURE 34.................... NOVARTIS AG: COMPANY SNAPSHOT (2021)
13.1.6 SANOFI
・ TABLE 384....................................... SANOFI: COMPANY OVERVIEW
・ FIGURE 35............................ SANOFI: COMPANY SNAPSHOT (2021)
13.1.7 BOEHRINGER INGELHEIM
・ TABLE 385............... BOEHRINGER INGELHEIM: COMPANY OVERVIEW
・ FIGURE 36..... BOEHRINGER INGELHEIM: COMPANY SNAPSHOT (2021)
13.1.8 BRISTOL-MYERS SQUIBB
・ TABLE 386................ BRISTOL-MYERS SQUIBB: COMPANY OVERVIEW
・ FIGURE 37...... BRISTOL-MYERS SQUIBB: COMPANY SNAPSHOT (2021)
13.1.9 ELI LILLY AND COMPANY
・ TABLE 387................. ELI LILLY AND COMPANY: COMPANY OVERVIEW
・ FIGURE 38....... ELI LILLY AND COMPANY: COMPANY SNAPSHOT (2021)
13.1.10 GLAXOSMITHKLINE PLC
・ TABLE 388.................. GLAXOSMITHKLINE PLC: COMPANY OVERVIEW
・ FIGURE 39........ GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT (2021)
13.1.11 MERCK & CO., INC.
・ TABLE 389........................ MERCK & CO., INC.: COMPANY OVERVIEW
・ FIGURE 40............. MERCK & CO., INC.: COMPANY SNAPSHOT (2021)
13.1.12 ABBVIE INC.
・ TABLE 390................................. ABBVIE INC.: COMPANY OVERVIEW
・ FIGURE 41...................... ABBVIE INC.: COMPANY SNAPSHOT (2021)
13.1.13 F. HOFFMANN-LA ROCHE LTD.
・ TABLE 391.......... F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
・ FIGURE 42. F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2021)
13.1.14 ASTRAZENECA
・ TABLE 392............................. ASTRAZENECA: COMPANY OVERVIEW
・ FIGURE 43................... ASTRAZENECA: COMPANY SNAPSHOT (2021)
13.1.15 DR. REDDY’S LABORATORIES LTD.
・ TABLE 393..... DR. REDDY’S LABORATORIES LTD.: COMPANY OVERVIEW
・ FIGURE 44.... DR. REDDY’S LABORATORIES LTD.: COMPANY SNAPSHOT (2021)
13.1.16 SUN PHARMACEUTICAL INDUSTRIES LTD.
・ TABLE 394......... SUN PHARMACEUTICAL INDUSTRIES LTD.: COMPANY OVERVIEW
・ FIGURE 45......... SUN PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT (2021)
13.1.17 CIPLA INC.
・ TABLE 395................................... CIPLA INC.: COMPANY OVERVIEW
・ FIGURE 46........................ CIPLA INC.: COMPANY SNAPSHOT (2021)
13.1.18 AUROBINDO PHARMA
・ TABLE 396.................... AUROBINDO PHARMA: COMPANY OVERVIEW
・ FIGURE 47.... AUROBINDO PHARMA LTD.: COMPANY SNAPSHOT (2021)
13.1.19 EVONIK INDUSTRIES AG
・ TABLE 397.................. EVONIK INDUSTRIES AG: COMPANY OVERVIEW
・ FIGURE 48................. EVONIK INDUSTRIES AG: COMPANY SNAPSHOT (2021)
*BUSINESS OVERVIEW, PRODUCTS/SERVICES/SOLUTIONS OFFERED, MNM VIEW, KEY STRENGTHS AND RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESSES AND COMPETITIVE THREATS, RECENT DEVELOPMENTS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
13.2 OTHER PLAYERS
13.2.1 API PHARMA TECH.. 368
13.2.2 BDR PHARMACEUTICALS INTERNATIONALS PVT. LTD.
13.2.3 SREEPATHI PHARMACEUTICALS LIMITED
13.2.4 SHILPA MEDICARE LIMITED